Goodwill of HAEMONETICS CORP from 03 Apr 2010 to 27 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
HAEMONETICS CORP quarterly Goodwill in USD history and change rate from 03 Apr 2010 to 27 Sep 2025.
  • HAEMONETICS CORP Goodwill for the quarter ending 27 Sep 2025 was $606,101,000, a 1.6% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

HAEMONETICS CORP Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $606,101,000 -$10,061,000 -1.6% 27 Sep 2025 10-Q 06 Nov 2025 2026 Q2
Q2 2025 $607,299,000 -$6,048,000 -0.99% 28 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 $604,269,000 +$39,187,000 +6.9% 29 Mar 2025 10-Q 06 Nov 2025 2026 Q2
Q4 2024 $605,266,000 +$50,267,000 +9.1% 28 Dec 2024 10-Q 06 Feb 2025 2025 Q3
Q3 2024 $616,162,000 +$150,757,000 +32% 28 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 $613,347,000 +$147,437,000 +32% 29 Jun 2024 10-Q 08 Aug 2024 2025 Q1
Q1 2024 $565,082,000 +$98,851,000 +21% 30 Mar 2024 10-K 21 May 2025 2025 FY
Q4 2023 $554,999,000 +$88,887,000 +19% 30 Dec 2023 10-Q 08 Feb 2024 2024 Q3
Q3 2023 $465,405,000 +$418,000 +0.09% 30 Sep 2023 10-Q 02 Nov 2023 2024 Q2
Q2 2023 $465,910,000 -$205,000 -0.04% 01 Jul 2023 10-Q 08 Aug 2023 2024 Q1
Q1 2023 $466,231,000 -$1,056,000 -0.23% 01 Apr 2023 10-K 21 May 2025 2025 FY
Q4 2022 $466,112,000 -$2,087,000 -0.45% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q3
Q3 2022 $464,987,000 -$3,603,000 -0.77% 01 Oct 2022 10-Q 08 Nov 2022 2023 Q2
Q2 2022 $466,115,000 -$199,000 -0.04% 02 Jul 2022 10-Q 10 Aug 2022 2023 Q1
Q1 2022 $467,287,000 +$843,000 +0.18% 02 Apr 2022 10-K 20 May 2024 2024 FY
Q4 2021 $468,199,000 +$252,691,000 +117% 01 Jan 2022 10-Q 08 Feb 2022 2022 Q3
Q3 2021 $468,590,000 +$253,996,000 +118% 02 Oct 2021 10-Q 09 Nov 2021 2022 Q2
Q2 2021 $466,314,000 +$249,016,000 +115% 03 Jul 2021 10-Q 11 Aug 2021 2022 Q1
Q1 2021 $466,444,000 +$255,792,000 +121% 03 Apr 2021 10-K 22 May 2023 2023 FY
Q4 2020 $215,508,000 +$4,446,000 +2.1% 26 Dec 2020 10-Q 02 Feb 2021 2021 Q3
Q3 2020 $214,594,000 +$3,553,000 +1.7% 26 Sep 2020 10-Q 04 Nov 2020 2021 Q2
Q2 2020 $217,298,000 +$6,158,000 +2.9% 27 Jun 2020 10-Q 04 Aug 2020 2021 Q1
Q1 2020 $210,652,000 -$167,000 -0.08% 28 Mar 2020 10-K 25 May 2022 2022 FY
Q4 2019 $211,062,000 +$339,000 +0.16% 28 Dec 2019 10-Q 04 Feb 2020 2020 Q3
Q3 2019 $211,041,000 +$197,000 +0.09% 28 Sep 2019 10-Q 01 Nov 2019 2020 Q2
Q2 2019 $211,140,000 +$237,000 +0.11% 29 Jun 2019 10-Q 06 Aug 2019 2020 Q1
Q1 2019 $210,819,000 -$576,000 -0.27% 30 Mar 2019 10-K 26 May 2021 2021 FY
Q4 2018 $210,723,000 -$363,000 -0.17% 29 Dec 2018 10-Q 05 Feb 2019 2019 Q3
Q3 2018 $210,844,000 -$281,000 -0.13% 29 Sep 2018 10-Q 06 Nov 2018 2019 Q2
Q2 2018 $210,903,000 -$27,000 -0.01% 30 Jun 2018 10-Q 07 Aug 2018 2019 Q1
Q1 2018 $211,395,000 +$554,000 +0.26% 31 Mar 2018 10-K 20 May 2020 2020 FY
Q4 2017 $211,086,000 -$56,228,000 -21% 30 Dec 2017 10-Q 06 Feb 2018 2018 Q3
Q3 2017 $211,125,000 -$57,421,000 -21% 30 Sep 2017 10-Q 07 Nov 2017 2018 Q2
Q2 2017 $210,930,000 -$57,659,000 -21% 01 Jul 2017 10-Q 07 Aug 2017 2018 Q1
Q1 2017 $210,841,000 -$56,999,000 -21% 01 Apr 2017 10-K 22 May 2019 2019 FY
Q4 2016 $267,314,000 +$369,000 +0.14% 31 Dec 2016 10-Q 06 Feb 2017 2017 Q3
Q3 2016 $268,546,000 -$65,029,000 -19% 01 Oct 2016 10-Q 07 Nov 2016 2017 Q2
Q2 2016 $268,589,000 -$65,598,000 -20% 02 Jul 2016 10-Q 01 Aug 2016 2017 Q1
Q1 2016 $267,840,000 -$66,470,000 -20% 02 Apr 2016 10-K 23 May 2018 2018 FY
Q4 2015 $266,945,000 -$68,045,000 -20% 26 Dec 2015 10-Q 02 Feb 2016 2016 Q3
Q3 2015 $333,575,000 -$2,726,000 -0.81% 26 Sep 2015 10-Q 04 Nov 2015 2016 Q2
Q2 2015 $334,187,000 -$3,050,000 -0.9% 27 Jun 2015 10-Q 30 Jul 2015 2016 Q1
Q1 2015 $334,310,000 -$2,458,000 -0.73% 28 Mar 2015 10-K 24 May 2017 2017 FY
Q4 2014 $334,990,000 -$2,039,000 -0.6% 27 Dec 2014 10-Q 05 Feb 2015 2015 Q3
Q3 2014 $336,301,000 -$5,372,000 -1.6% 27 Sep 2014 10-Q 04 Nov 2014 2015 Q2
Q2 2014 $337,237,000 -$4,272,000 -1.3% 28 Jun 2014 10-Q 31 Jul 2014 2015 Q1
Q1 2014 $336,768,000 +$6,294,000 +1.9% 29 Mar 2014 10-K 01 Jun 2016 2016 FY
Q4 2013 $337,029,000 +$15,745,000 +4.9% 28 Dec 2013 10-Q 30 Jan 2014 2013 Q3
Q3 2013 $341,673,000 +$19,559,000 +6.1% 28 Sep 2013 10-Q 30 Oct 2013 2013 Q2
Q2 2013 $341,509,000 +$226,461,000 +197% 29 Jun 2013 10-Q 02 Aug 2013 2013 Q1
Q1 2013 $330,474,000 +$215,416,000 +187% 30 Mar 2013 10-K 22 May 2015 2015 FY
Q4 2012 $321,284,000 +$205,964,000 +179% 29 Dec 2012 10-Q 01 Feb 2013 2012 Q3
Q3 2012 $322,114,000 +$206,532,000 +179% 29 Sep 2012 10-Q 07 Nov 2012 2012 Q2
Q2 2012 $115,048,000 -$659,000 -0.57% 30 Jun 2012 10-Q 08 Aug 2012 2012 Q1
Q1 2012 $115,058,000 -$309,000 -0.27% 31 Mar 2012 10-K 22 May 2014 2013 FY
Q4 2011 $115,320,000 +$4,052,000 +3.6% 31 Dec 2011 10-Q 06 Feb 2012 2011 Q3
Q3 2011 $115,582,000 +$3,199,000 +2.8% 01 Oct 2011 10-Q 03 Nov 2011 2011 Q2
Q2 2011 $115,707,000 -$2,032,000 -1.7% 02 Jul 2011 10-Q 10 Aug 2011 2011 Q1
Q1 2011 $115,367,000 +$5,379,000 +4.9% 02 Apr 2011 10-K 20 May 2013 2012 FY
Q4 2010 $111,268,000 01 Jan 2011 10-Q 08 Feb 2011 2010 Q3
Q3 2010 $112,383,000 02 Oct 2010 10-Q 10 Nov 2010 2010 Q2
Q2 2010 $117,739,000 03 Jul 2010 10-Q 11 Aug 2010 2010 Q1
Q1 2010 $109,988,000 03 Apr 2010 10-K 22 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.